Viewing Study NCT01367158


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-05-27 @ 8:12 AM
Study NCT ID: NCT01367158
Status: COMPLETED
Last Update Posted: 2014-11-19
First Post: 2011-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
Sponsor: Novartis Vaccines
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Meningococcal Disease View
None Meningococcal Meningitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Meningococcal disease View
None vaccines View
None adolescents View
None prevention View
None Meningitis View